China Interventional Cardiovascular Device Industry Report,2014-2017
  • Sep.2014
  • Hard Copy
  • USD $2,400
  • Pages:112
  • Single User License
    (PDF Unprintable)       
  • USD $2,200
  • Code: ZLC009
  • Enterprise-wide License
    (PDF Printable & Editable)       
  • USD $3,500
  • Hard Copy + Single User License
  • USD $2,600

The prevalence of cardiovascular disease in China impacted by accelerated aging of population and changes in consumption concept, dietary habit, way of working and other lifestyles has been growing year after year, thereby promoting the development of domestic percutaneous coronary intervention (PCI) market. PCI cases in China totaled 454,505 in 2013, up 16.9% from a year earlier; meanwhile the interventional cardiovascular device industry there was worth RMB20.12 billion.

At present, half of the Chinese interventional cardiovascular device industry is dominated by domestic companies led by MicroPort, Lepu Medical, Lifetech Scientific, and Dalian Yinyi. In 2013, 53.4% of the Chinese market was controlled by domestic companies, 31.2% by foreign counterparts represented by Johnson & Johnson, Medtronic, Boston Scientific, Abbott, B. Braun and Terumo, and 15.4% by those invested by Hong Kong, Macao and Taiwan.

Interventional cardiovascular devices in China include cardiovascular stent, catheter, guidewire, balloon, surgical auxiliary devices, etc., among which cardiovascular stent is predominant.

Cardiovascular stent: In 2013, the Chinese cardiovascular stent market equaled RMB11.2 billion, 78.8% of which was occupied by domestic drug-eluting stents. That same year, 686,000 units of cardiovascular stent were consumed in China, up 11.7% year on year, and drug-eluting stents accounted for 99.5%, indicating that the drug-eluting stent is gradually becoming an important device for interventional cardiovascular therapy.

In addition, Abbott has developed biodegradable stents, which are sold in Europe; Lepu Medical is endeavoring to develop biodegradable stents, which are expected to be available on the market in 2017. Thanks to its excellent performance, biodegradable stents are likely to replace drug-eluting stents gradually in the future, thus becoming the main variety in domestic coronary stent market.

Balloon catheter: In 2013, China’s demand for PTCA balloon catheter amounted to 1.186 million units, 500,000 of which were PTCA balloon catheters for dilatation. With rapid development of local PTCA balloon catheter producers represented by Lepu Medical, MicroPort and JW Medical, domestic PTCA balloon catheters increased its market share from 20% in 2009 to 40% in 2013.

Affected by the implementation of “Regulations on the Centralized Procurement of High-value Medical Consumables”, purchase price of interventional cardiovascular devices will continue to decline, further squeezing profit margins of relevant companies. However, the substantial decline in prices will enable more patients to receive PCI, thus helping the industry maintain a fairly rapid growth rate. It is expected that the Chinese interventional cardiovascular device market will worth RMB41.2 billion by 2017.

心血管介入器械 英文_副本.png

China Interventional Cardiovascular Device Industry Report, 2014-2017 focuses on the following:
20120114.gifStatus quo of China interventional cardiovascular device industry, including overview, market demand, import & export, competitive landscape and entry barriers;
20120114.gifDevelopment environment of China interventional cardiovascular device industry, embracing macro environment, policy climate and upstream & downstream sectors;
20120114.gifStatus quo, competitive landscape, etc. of China interventional cardiovascular device market segments, covering coronary stent, balloon catheter, catheter, guidewire, sheath group and auxiliary devices;
20120114.gifOperation, interventional cardiovascular device business, etc. of 6 foreign and 12 Chinese interventional cardiovascular device companies.

1. Overview of Interventional Cardiovascular Device Industry 
1.1 Definition
1.2 Classification and Application of Products 
1.3 Industry Chain

2. Status Quo of China Interventional Cardiovascular Device Industry
2.1 Overview
2.2 Market Demand
2.3 Import & Export
2.4 Competitive Landscape
2.5 Entry Barriers
2.5.1 Technology
2.5.2 Talent
2.5.3 Patent
2.5.4 Policy
2.5.5 Market Channel

3. Development Environment of China Interventional Cardiovascular Device Industry
3.1 Macro Environment
3.2 Policy Climate
3.2.1 Regulatory Policies
3.2.2 Industrial Policies
3.3 Upstream & Downstream Sectors
3.3.1 Upstream
3.3.2 Downstream

4. Market Segments of China Interventional Cardiovascular Device Industry
4.1 Coronary Stent
4.1.1 Market Profile
4.1.2 Drug-Eluting Stent
4.1.3 Bioabsorbable Stent
4.2 Balloon Catheter
4.2.1 Market Profile
4.2.2 Supply & Demand
4.3 Catheter
4.4 Guidewire
4.5 Sheath Group and Auxiliary Devices

5. Foreign Companies in China
5.1 Johnson & Johnson
5.1.1 Profile
5.1.2 Operation
5.1.3 Revenue Structure
5.1.4 Gross Margin
5.1.5 Interventional Cardiovascular Device Business
5.1.6 Development in China
5.2 Medtronic
5.2.1 Profile
5.2.2 Operation
5.2.3 Interventional Cardiovascular Device Business
5.2.4 Development in China
5.3 Boston Scientific
5.3.1 Profile
5.3.2 Operation
5.3.3 Interventional Cardiovascular Device Business
5.3.4 Development in China
5.4 Abbott Laboratories
5.4.1 Profile
5.4.2 Operation
5.4.3 Interventional Cardiovascular Device Business
5.4.4 Development in China
5.5 B. Braun
5.5.1 Profile
5.5.2 Operation
5.5.3 Interventional Cardiovascular Device Business
5.5.4 Development in China
5.6 Terumo
5.6.1 Profile
5.6.2 Operation
5.6.3 Interventional Cardiovascular Device Business
5.6.4 Development in China

6. Major Domestic Companies
6.1 MicroPort
6.1.1 Profile
6.1.2 Operation
6.1.3 Revenue Structure
6.1.4 Interventional Cardiovascular Device Business
6.1.5 R&D and Investment
6.1.6 Forecast and Outlook
6.2 Lepu Medical
6.2.1 Profile
6.2.2 Operation
6.2.3 Revenue Structure
6.2.4 Gross Margin
6.2.5 Interventional Cardiovascular Device Business
6.2.6 R&D and Investment
6.2.7 Forecast and Outlook
6.3 Lifetech Scientific
6.3.1 Profile
6.3.2 Operation
6.3.3 Revenue Structure
6.3.4 Interventional Cardiovascular Device Business
6.3.5 R&D and Investment
6.3.6 Forecast and Outlook
6.4 JW Medical
6.4.1 Profile
6.4.2 Interventional Cardiovascular Device Business
6.5 Dalian Yinyi
6.5.1 Profile
6.5.2 Interventional Cardiovascular Device Business
6.6 Neich Medical (Shenzhen)
6.6.1 Profile
6.6.2 Interventional Cardiovascular Device Business
6.7 SCW Medicath
6.7.1 Profile
6.7.2 Interventional Cardiovascular Device Business
6.8 Demax Medical
6.8.1 Profile
6.8.2 Interventional Cardiovascular Device Business
6.9 Starway Medical
6.9.1 Profile
6.9.2 Interventional Cardiovascular Device Business
6.10 Synexmed
6.10.1 Profile
6.10.2 Interventional Cardiovascular Device Business
6.11 Sino Medical
6.11.1 Profile
6.11.2 Interventional Cardiovascular Device Business
6.12 AmsinoMed Medical Device
6.12.1 Profile
6.12.2 Interventional Cardiovascular Device Business

7 Forecast and Outlook
7.1 Industry
7.2 Market Segments
7.2.1 Coronary Stent
7.2.2 Balloon Catheter
Types and Functions of Interventional Cardiovascular Device 
Types and Features of Cardiovascular Stent 
Interventional Cardiovascular Device Industry Chain in China
Total Industrial Output Value and YoY Growth of China Medical Device Industry, 2005-2013
Revenue and YoY Growth of China Medical Device Industry, 2005-2013
Market Size and YoY Growth of China Interventional Cardiovascular Device Industry, 2009-2013
Number of Patients with Cardiovascular Disease in China, 2013
Death Rate Percentage of Major Diseases in Rural Area, 2012
Death Rate Percentage of Major Diseases in Urban Area, 2012
Changes in Mortality Rate of Coronary Heart Disease in Urban and Rural Areas of China, 2002-2011
Number of PCI Cases and Growth Rate in China, 2011-2013
Coronary Stent Implantation and Usage Percentage of Drug-eluting Stent in China, 2011-2013
Import Share and Import Prices of Main Interventional Medical Devices in China, 2008
China’s Intravascular Stent Imports and Exports by Top 10 Countries, 2013
Market Structure of China Interventional Cardiovascular Device Industry, 2013
Number of Congenital Heart Disease Patients Receiving Interventional Therapy in China, 2012-2013
Business Models of China Interventional Cardiovascular Device Industry
China’s GDP and YoY Growth, 1985-2013
Main Policies Concerning Interventional Cardiovascular Device in China, 2006-2013
Number of Medical Institutions and Sickbeds in China, 2012-2013
Number of Hospitals in China (by Grade), 2010-Jun. 2014
Medical Service Quantity of Health Care Facilities in China, 2012-2013
Usage of Sickbeds in China’s Medical Institutions, 2012-2013
Health Costs and % of GDP in China, 1980-2013
Per Capita Health Costs and YoY Growth Rate in China, 2006-2013
Number of People 65 and Over and % of Total Population in China, 2004-2013
Ratio between Per Capita Income of Urban and Rural Households in China, 1980-2013
Medical Insurance Coverage and Expenditure in China
Proportion of Medical Insurance-covered Payment for Interventional Operation in Beijing, Shanghai and Guangzhou, 2011
Market Share of China-made Coronary Drug-eluting Stent System, 2009-2013
Market Share of Main Coronary Stent System Brands in China (by Consumption), 2013
Implantation of Coronary Stent in China, 2011-2013
China’s Coronary Stent Market Size and YoY Growth, 2012-2017E
Comparison of Relevant Data about PCI in China, 2011-2013
List of Main Domestic Drug-eluting Stent Products, 2013
Market Share of Imported and Domestic PTCA Balloon Catheter Products, 2013
China's Interventional Cardiovascular Balloon Catheter Market Size, 2012-2017E
China’s Demand for PTCA Balloon Catheter, 2011-2013
China's Interventional Cardiovascular Catheter Market Size, 2012-2017E
China's Interventional Cardiovascular Guide Wire Market Size, 2012-2017E
China's Interventional Cardiovascular Sheath Group and Auxiliary Device Market Size, 2012-2017E
Total Revenue and Net Income of Johnson & Johnson, 2009-2014
Total Revenue Breakdown of Johnson & Johnson (by Product), 2009-2014
Total Revenue Structure of Johnson & Johnson (by Product), 2009-2014
Gross Margin of Johnson & Johnson, 2009-2014
Johnson & Johnson’s Revenue from Cardiovascular Business and YoY Growth, 2009-2013
Johnson & Johnson’s Companies in China and Their Main Products
Revenue and Net Income of Medtronic, FY2009-FY2013
Revenue Breakdown of Medtronic (by Product), FY2009-FY2013
Revenue Structure of Medtronic (by Product), FY2009-FY2013
Medtronic’s Revenue from Coronary Artery Products and % of Total Revenue, FY2009-FY2013
Revenue, Net Income and Gross Margin of Boston Scientific, 2009-2013
Revenue Breakdown of Boston Scientific (by Division), 2009-2013
Revenue Breakdown of Boston Scientific (by Region), 2009-2013
Boston Scientific’s Revenue from Cardiovascular Division and YoY Growth, 2009-2013
Revenue, Net Income and Gross Margin of Abbott, 2009-2013
Revenue Breakdown of Abbott (by Product), 2009-2013
Revenue Structure of Abbott (by Product), 2009-2013
Revenue from Cardiovascular Products and % of Total Revenue, 2009-2013
Revenue, Net Income and Gross Margin of B. Braun, 2009-2013
Revenue Breakdown of B. Braun (by Division), 2009-2013
Revenue Breakdown of B. Braun (by Region), 2009-2013
Revenue and YoY Growth of B. Braun's Aesculap Division, 2009-2013
Revenue and Net Income of Terumo, FY2010-FY2013
Revenue of Terumo by Business, FY2010-FY2013
Revenue of Terumo by Region, FY2010-FY2013
R&D Cost and Proportion in Revenue of Terumo, FY2010-FY2013
Revenue from Cardiovascular Business and Revenue Share of Terumo, FY2010-FY2013
PTCA Balloon Dilatation Catheter Output and YoY Growth of Terumo, FY2009-FY2013
Angiographic Guidewire Output and YoY Growth of Terumo, FY2009-FY2013
PTCA Guidewire Output and YoY Growth of Terumo, FY2009-FY2013
China Branches and Their Business of Terumo
Terumo’s Layout in China
Revenue, Net Income and Gross Margin of MicroPort, 2009-2013
Revenue Breakdown of MicroPort (by Product), 2011-2013
Revenue Structure of MicroPort (by Product), 2011-2013
Revenue Breakdown of MicroPort (by Region), 2009-2013
Revenue Structure of MicroPort (by Region), 2009-2013
MicroPort’s Revenue from Interventional Cardiovascular Products and % of Total Revenue, 2011-2013
MicroPort’s Advantages in Heart Drug-eluting Stent Field
R&D Costs and % of Total Revenue of MicroPort, 2009-2013
Revenue and Net Income of MicroPort, 2012-2017E
Distribution of Lepu Medical’s Subsidiaries
Revenue, Net Income and Gross Margin of Lepu Medical, 2009-2013
Revenue Breakdown of Lepu Medical (by Product), 2009-2013
Revenue Breakdown of Lepu Medical (by Region), 2009-2013
Gross Margin of Lepu Medical (by Product), 2009-2013
R&D Costs and % of Total Revenue of Lepu Medical, 2010-2013
Lepu Medical’s Projects with Raised Funds and Progress
Revenue and Net Income of Lepu Medical, 2012-2017E
Revenue, Net Income and Gross Margin of Lifetech Scientific, 2009-2013
Revenue Breakdown of Lifetech Scientific (by Business), 2009-2013
Revenue Structure of Lifetech Scientific (by Business), 2009-2013
Lifetech Scientific’s Revenue from Congenital Heart Disease Business, YoY Growth and % of Total Revenue, 2009-2013
Lifetech Scientific’s Revenue from Peripheral Vascular Disease Business, YoY Growth and % of Total Revenue, 2009-2013
R&D Costs, YoY Growth and % of Total Revenue of Lifetech Scientific, 2010-2013
Revenue and Net Income of Lifetech Scientific, 2012-2017E
Balloon Compliance of JW Medical’s EXCEL Drug-eluting Stent Delivery System
Features of Dalian Yinyi’s Balloon Dilatation Catheters
Technical Parameters of COMBO Dual Therapy Stent
SCW Medicath’s PTCA Balloon Dilatation Catheters
Features and Advantages of SCW Medicath’s PTCA Balloon Dilatation Catheters
Technical Parameters of SCW Medicath’s PTCA Balloon Dilatation Catheters
Technical Parameters of Demax Medical’s Gusta? PTCA Balloon Dilatation Catheters
Technical Parameters of Demax Medical’s Gusta? PTCA Non-compliance Balloon Dilatation Catheters
Main Technical Parameters of Synexmed’s Advancer? PTCA Balloon Catheter
Main Technical Parameters of Synexmed’s Advancer Plus? PTCA/CTO Balloon Catheter
Main Technical Parameters of Synexmed’s Advancer Hp? High Pressure Balloon Catheter
Technical Parameters of Synexmed’s RUNNER? Coronary Stent
Technical Parameters of Synexmed’s CHALLENGER? Coronary Stent
Technical Parameters of Synexmed’s RAPA? Rapamycin Drug-eluting Coronary Stent
Technical Parameters of Sino Medical’s BuMA? Drug-eluting Stent
Technical Parameters of Sino Medical’s SUN Coronary Stent
Diagram for Balloon Passing External Diameter of Sino Medical’s Sleek PTCA Rapid Exchange Dilatation Balloon Catheter
Market Size and YoY Growth of China Interventional Cardiovascular Device Industry, 2012-2017E

China Dental Industry Report, 2014-2018

Oral industry refers to the medical industry chain on the basis of oral medical consumption, mainly covering oral medical apparatus (equipment and consumables) and oral medical services. As reform of ...

China Medical Monitor Industry Report, 2014-2017

With advancement of medical reform, improvement of spending power, and enhancement of health care consciousness, China’s medical monitor industry is gradually expanding. During 2007-2013, the market s...

China Independent Clinical Laboratory Industry Report, 2014-2017

The independent clinical laboratory industry starts relatively late in China, featuring a limited overall size but high-speed development. In 2013 the independent clinical laboratory market size there...

China Interventional Cardiovascular Device Industry Report,2014-2017

The prevalence of cardiovascular disease in China impacted by accelerated aging of population and changes in consumption concept, dietary habit, way of working and other lifestyles has been growing ye...

China PTCA Balloon Market Investment Report, 2014-2016

PTCA balloon, as a indispensable medical device in percutaneous coronary intervention (PCI), serves not only as a delivery system for stent, but also as a device for pre-/post-stent dilatations. There...

China Orthopedic Instrument Industry Report, 2014-2017

Benefiting from accelerated aging population and rising proportion of reimbursement for medical expenses, the Chinese orthopedic instrument market demand has been effectively released, with its scale ...

China Hospital Development and Investment Report, 2014-2017

China hospital industry has been developing quickly in recent years, thanks to the market demand stimulus and steady progress in health care reform. The number of Chinese hospitals grew at a CAGR of 6...

China Diagnostic Reagent Industry Report, 2013-2016

With the accelerated aging of the Chinese population, the increase of personal health expenditure as well as the improved medical care facilities and government health care system, China diagnostic re...

China Hemodialysis Equipment Import and Export Report, 2013-2016

Hemodialysis equipment is the most widely used treatment apparatus in blood purification, primarily targeting patients with acute or chronic renal failure.The Chinese hemodialysis equipment market sho...

Global and China Hemodialysis Industry Report, 2013-2016

Hemodialysis, also known as artificial kidney, is a type of blood purification technology, primarily applicable to the treatment of patients with rental failure. In 2013, the global number of patient...

China Portable Medical Equipment Industry Report, 2013-2016

With the synergy of favorable policies, improvement in living standards and healthcare awareness raising, China’s portable medical device industry has shown rapid development in recent years, with mar...

China Medical Informatization Industry Report,2013-2016

Under the impetus of multiple favorable policies and market demand, China's medical informatization industry has entered a rapid development stage in recent years. As of the first half of 2013, manage...

China Aged Care Industry Report, 2013-2016

Currently, China has entered the accelerated aging period. China’s population aged 65 and above reached 131.61 million in 2013, accounting for 9.7% of total population; and the proportion will rise to...

China Pharmaceutical Equipment Industry Report, 2013-2016

After decades of development, China has become a major producer of pharmaceutical equipment in the world. Since 2010, affected by the new GMP certification and other factors, the revenue and total pro...

China Dental Industry Report, 2013-2016

The dental industry refers to medical industrial chain on the basis of oral medical consumption, consisting mainly of dental appliances (equipments and consumables), dental medical services, etc. with...

China Medical Monitor Industry Report, 2013-2015

In 2007-2011, the Chinese medical monitor market size rose from RMB1.16 billion to RMB3.08 billion at a CAGR of 27.8%. In 2012, the figure reached RMB3.86 billion, a year-on-year increase of 25.3%, of...

China Interventional Cardiovascular Device Industry Report, 2013-2015

With the accelerated aging, the prevalence of cardiovascular diseases in China increased year by year. According to statistics of National Health and Family Planning Commission of the People’s Republi...

China Diagnostic Reagent Industry Report, 2013-2015

Driven by huge population base, intensified aging and many favorable policies, China diagnostic reagent industry has been developing rapidly. In 2008-2012, the diagnostic reagent market size presented...

2005-2014 All Rights Reserved 京ICP备05069564号-1 京公网安备1101054484号